PQB3: Mechanisms & Targeting of Sonic Hedgehog Signaling in Muscle Wasting of Cancer Cachexia
PQB3:机制
基本信息
- 批准号:9052746
- 负责人:
- 金额:$ 35.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-10 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultBiochemicalBiological PreservationCachexiaCancer PatientCatabolismCell Culture TechniquesCessation of lifeClinical DataClinical TrialsCorrelative StudyDataDiseaseExhibitsFDA approvedFatty acid glycerol estersFiberFutureGLI geneGoalsGrowthHealthHousingHumanHypertrophyIn VitroLengthLifeMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of pancreasMeasuresModelingMolecularMorbidity - disease rateMusMuscleMuscle DevelopmentMuscle functionMuscle satellite cellMuscular AtrophyMyoblastsNuclearPAX7 genePathway interactionsPatientsProcessProteinsProteolysisQuality of lifeRhabdomyosarcomaSHH geneShapesSignal TransductionSkeletal MuscleSonic Hedgehog PathwayStem cellsTestingToxicity due to chemotherapyTreatment-Related CancerUbiquitinWorkcancer cachexiaclinically relevantcytokineimprovedin vivoinhibitor/antagonistmortalitymuscle formmuscle regenerationpre-clinicalpreventprogenitorresponsesmall molecule inhibitorsmoothened signaling pathwaytherapeutic targettreatment responsetumortumor growthwasting
项目摘要
DESCRIPTION (provided by applicant): Cachexia is sometimes viewed as a harbinger of inevitable death in cancer, which only can be addressed by curing the disease. While curing cancer should cure cachexia, many cancers have dismal cure rates. Muscle loss causes chemotherapy toxicity, poor quality of life, poor response to therapies, and is often blamed for up to 30% of cancer deaths. However, compelling data from our lab and others show that blocking muscle wasting can prolong function and life in mice with cancer, despite continued growth of the tumor. These findings indicate that muscle loss is a major contributor to cancer morbidity and mortality and it can be targeted to increase length and quality of life for cancer patients. Our goal is to understand the molecular pathways responsible for cachexia in order to shape rational therapies to prevent it. Sonic hedgehog (Shh) regulates proliferation and differentiation of progenitor cells in the adult and is essential for muscle development and modulates muscle regeneration. Here, we provide evidence that cachexia-inducing cytokines and tumors stimulate Shh signaling in muscle. Skeletal muscle from mice and patients with high cytokines and cancer cachexia exhibit Shh pathway activation. In mice and cell cultures, activation of Shh signaling causes muscle atrophy, while antagonism results in hypertrophy. Encouragingly, an FDA-approved inhibitor of the Shh pathway, GDC-0449/vismodegib, reduced muscle and fat wasting in mice with cancer cachexia. The Shh pathway promoted ubiquitin-associated proteolysis in muscle, which was reversed by Shh inhibition. Additionally, Shh action promoted proliferation of myoblasts, while blocking normal myogenic differentiation. From these data we hypothesize that Shh pathway activation drives muscle wasting through dual effects on protein catabolism in myofibers and differentiation of muscle progenitors. Accumulation of muscle progenitors leads to expression of cytokines, which in turn induces wasting of myofibers. Signaling in myofibers leads directly to protein loss and wasting. Thus Shh signaling is a therapeutic target to prevent cancer cachexia. Here we will test this hypothesis and define the relevance of this pathway to the potential treatment and pathobiology of human pancreatic cancer cachexia. These studies will shape future clinical trials for targeting cancer cachexia to improve treatment response and survival in cancer.
描述(由申请人提供):恶病质有时被视为癌症不可避免的死亡的预兆,只能通过治愈疾病来解决。 虽然治愈癌症应该治愈恶病质,但许多癌症的治愈率很低。生活质量差、对治疗的反应不佳,通常被认为是高达 30% 的癌症死亡的原因。然而,来自我们实验室和其他实验室的令人信服的数据表明,阻止肌肉萎缩可以延长小鼠的功能和寿命。尽管肿瘤持续生长,但这些发现表明肌肉损失是癌症发病率和死亡率的一个主要因素,我们的目标是了解导致癌症患者生活长度和质量的分子途径。声波刺猬 (Shh) 调节成人祖细胞的增殖和分化,对于肌肉发育和调节肌肉再生至关重要。在此,我们提供了诱导恶病质的细胞因子和肿瘤的证据。刺激肌肉中的 Shh 信号传导。来自具有高细胞因子和癌症恶病质的小鼠和患者的骨骼肌表现出 Shh 信号通路激活。在小鼠和细胞培养物中,Shh 信号传导的激活会导致肌肉萎缩,而令人鼓舞的是,FDA 批准的一种抑制剂会导致肌肉肥大。 Shh 通路 GDC-0449/vismodegib 减少了癌症恶病质小鼠的肌肉和脂肪消耗。Shh 通路促进了泛素相关的蛋白水解。此外,Shh 作用促进了成肌细胞的增殖,同时阻止了正常的肌原性分化。根据这些数据,我们探索了 Shh 通路激活通过对肌纤维中的蛋白质分解代谢和肌肉祖细胞分化的双重作用而导致肌肉萎缩。肌肉祖细胞的积累导致细胞因子的表达,进而诱导肌纤维中的信号传导直接导致蛋白质损失和浪费。在这里,我们将测试这一假设,并确定该途径与人类胰腺癌恶病质的潜在治疗和病理学的相关性,这些研究将塑造未来针对癌症恶病质的临床试验,以改善治疗反应和治疗效果。癌症中的生存。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa A Zimmers其他文献
Teresa A Zimmers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa A Zimmers', 18)}}的其他基金
Enhancing Diversity and Addressing Disparities at the 7th Cancer Cachexia Conference
第七届癌症恶病质会议增强多样性并解决差异
- 批准号:
10827795 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
项目 1 — 胰腺癌宏观环境中脂肪-肌肉串扰中的 IL-6/STAT3/NF-kB
- 批准号:
10634574 - 财政年份:2021
- 资助金额:
$ 35.41万 - 项目类别:
Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
项目 1 — 胰腺癌宏观环境中脂肪-肌肉串扰中的 IL-6/STAT3/NF-kB
- 批准号:
10634574 - 财政年份:2021
- 资助金额:
$ 35.41万 - 项目类别:
Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
项目 1 — 胰腺癌宏观环境中脂肪-肌肉串扰中的 IL-6/STAT3/NF-kB
- 批准号:
10441211 - 财政年份:2021
- 资助金额:
$ 35.41万 - 项目类别:
Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
项目 1 — 胰腺癌宏观环境中脂肪-肌肉串扰中的 IL-6/STAT3/NF-kB
- 批准号:
10172469 - 财政年份:2021
- 资助金额:
$ 35.41万 - 项目类别:
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
PQ6:Lipocalin-2 作为预防癌症恶病质的治疗靶点
- 批准号:
10600856 - 财政年份:2021
- 资助金额:
$ 35.41万 - 项目类别:
Tumor tissue crosstalk in the macroenvironment of pancreatic cancer cachexia
胰腺癌恶病质大环境中的肿瘤组织串扰
- 批准号:
10704535 - 财政年份:2020
- 资助金额:
$ 35.41万 - 项目类别:
Tumor tissue crosstalk in the macroenvironment of pancreatic cancer cachexia
胰腺癌恶病质大环境中的肿瘤组织串扰
- 批准号:
10425256 - 财政年份:2020
- 资助金额:
$ 35.41万 - 项目类别:
Tumor tissue crosstalk in the macroenvironment of pancreatic cancer cachexia
胰腺癌恶病质大环境中的肿瘤组织串扰
- 批准号:
9892488 - 财政年份:2020
- 资助金额:
$ 35.41万 - 项目类别:
Molecular Mechanisms of Muscle and Fat Wasting in Pancreatic Cancer Cachexia
胰腺癌恶病质中肌肉和脂肪消耗的分子机制
- 批准号:
10159842 - 财政年份:2018
- 资助金额:
$ 35.41万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms Underpinning Afterload-Induced Atrial Fibrillation
后负荷诱发心房颤动的机制
- 批准号:
10679796 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Toward therapeutic targeting of liquid-liquid phase separation dynamics in skin
皮肤液-液相分离动力学的治疗靶向
- 批准号:
10679610 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Assessing the real-world impact of a low nicotine product standard for smoked tobacco in New Zealand
评估新西兰低尼古丁产品标准对吸食烟草的现实影响
- 批准号:
10665851 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
Molecular Mechanisms Underlying Cytoneme Formation by Sonic Hedgehog-Producing Cells
Sonic Hedgehog 产生细胞形成细胞因子的分子机制
- 批准号:
10678288 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别:
A wearable device for continuous monitoring of methadone
用于连续监测美沙酮的可穿戴设备
- 批准号:
10787069 - 财政年份:2023
- 资助金额:
$ 35.41万 - 项目类别: